619 related articles for article (PubMed ID: 11422747)
1. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
2. Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study.
García del Moral R; O'Valle F; Andújar M; Aguilar M; Lucena MA; López-Hidalgo J; Ramírez C; Medina-Cano MT; Aguilar D; Gómez-Morales M
Am J Pathol; 1995 Feb; 146(2):398-408. PubMed ID: 7856751
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
[TBL] [Abstract][Full Text] [Related]
4. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
5. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.
Pankewycz OG; Miao L; Isaacs R; Guan J; Pruett T; Haussmann G; Sturgill BC
Kidney Int; 1996 Nov; 50(5):1634-40. PubMed ID: 8914030
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M
J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
8. Modifying cyclosporine associated renal allograft dysfunction.
Mohapatra N; Vanikar AV; Patel RD; Trivedi HL
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):770-4. PubMed ID: 19736471
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells.
Hauser IA; Koziolek M; Hopfer U; Thévenod F
Kidney Int; 1998 Oct; 54(4):1139-49. PubMed ID: 9767529
[TBL] [Abstract][Full Text] [Related]
10. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
11. Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
del Moral RG; Andujar M; Ramírez C; Gómez-Morales M; Masseroli M; Aguilar M; Olmo A; Arrebola F; Guillén M; García-Chicano MJ; Nogales FF; O'Valle F
Am J Pathol; 1997 Dec; 151(6):1705-14. PubMed ID: 9403721
[TBL] [Abstract][Full Text] [Related]
12. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
13. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
[TBL] [Abstract][Full Text] [Related]
14. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome.
Savikko J; Teppo AM; Taskinen E; von Willebrand E
Transpl Immunol; 2014 Sep; 31(3):145-51. PubMed ID: 25158212
[TBL] [Abstract][Full Text] [Related]
15. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
[TBL] [Abstract][Full Text] [Related]
16. CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection.
Gaweco AS; Mitchell BL; Lucas BA; McClatchey KD; Van Thiel DH
Kidney Int; 1999 Apr; 55(4):1543-52. PubMed ID: 10201021
[TBL] [Abstract][Full Text] [Related]
17. Kidney-specific deletion of multidrug resistance-related protein 2 does not aggravate acute cyclosporine A nephrotoxicity in rats.
Mähler N; Freyer M; Kauschke R; Schlüter T; Steinbach AC; Oswald S; Miehe B; Krebs A; Rettig R; Grisk O
Pharmacogenet Genomics; 2012 Jun; 22(6):408-20. PubMed ID: 21869731
[TBL] [Abstract][Full Text] [Related]
18. C4d positivity is often associated with acute cellular rejection in renal transplant biopsies following Campath-1H (Alemtuzumab) induction.
Zhang PL; Malek SK; Blasick TM; Pennington JR; Masker KK; Lun M; Potdar S
Ann Clin Lab Sci; 2007; 37(2):121-6. PubMed ID: 17522366
[TBL] [Abstract][Full Text] [Related]
19. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
Solez K; Vincenti F; Filo RS
Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
